References
- Kauffman CA. Candiduria. Clin Infect Dis 2005; 41: 371–376.
- Paul N, Mathai E, Abraham OC, Mathai D. Emerging microbiological trends in candiduria. Clin Infect Dis 2004; 39: 1743–1744.
- Malani AN, Kauffman CA. Candida urinary tract infections: treatment options. Expert Rev Anti Infect Ther 2007; 5: 77–84.
- Hazen KC, Howell SA. Candida, Cryptococcus, and other yeasts of medical importance. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, (eds). Manual of Clinical Microbiology, 9th ed. Washington, DC: ASM Press; 2007: 1762–1788.
- Larone DH. Monomorphic yeasts and yeastlike organisms. In: Medically Important Fungi: A Guide to Identification, 3th ed. Washington, DC: ASM Press, 2002: 21–23.
- Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, approved standard, Document M27-A3, 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
- Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Informational supplement, Document M27-S3, 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
- Diekema DJ, Messer SA, Boyken LB, . In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods. J Clin Microbiol 2009; 47: 3170–3177.
- de Oliveira RD, Maffei CM, Martinez R. Nosocomial urinary tract infections by Candida species. Rev Assoc Med Bras 2001; 47: 231–235.
- Chakrabarti A, Reddy TCS, Singhi S. Does candiduria predict candidemia? Indian J Med Res 1997; 106: 513–516.
- Kobayashi CCBA, Fernandes OFL, Miranda KC, deSousa ED, Silva MRR. Candiduria in hospital patients: a study prospective. Mycopathologia 2004; 158: 49–52.
- Safdar N, Slattery WR, Knasinski V, . Predictors and outcomes of candiduria in renal transplant recipients. Clin Infect Dis 2005; 40: 1413–1421.
- Fisher JF, Sobel JD, Kauffman CA, Newman CA. Candida urinary tract infections-treatment. Clin Infect Dis 2011; 52(Suppl. 6): 457–466.
- Arıkan S, Rex JH. Antifungal agents. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, (eds). Manual of Clinical Microbiology, 9th ed. Washington, DC: ASM Press; 2007: 1949–1960.
- Pappas PG, Kauffman CA, Andes D, . Clinical practice guideline for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503–535.
- Fisher JF, Woeltje K, Espinel-Ingroff A, Stanfield J, DiPiro JT. Efficacy of a single intravenous dose of amphotericin B for Candida urinary tract infections: further favorable experience. Clin Microbiol Infect 2003; 9: 1024–1027.
- Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 2004; 42: 4419–4431.
- Sobel JD, Bradshaw SK, Lipka CJ, Kartsonis NA. Caspofungin in the treatment of symptomatic candiduria. Clin Infect Dis 2007; 44: 46–49.